![](https://investchronicle.com/wp-content/uploads/2019/06/investchronicle-90-e1579508100610-300x197.png)
Company’s Banking Stock: Dissecting a 13.49% Quarterly Revenue Decline Amid Growth
The market performance of Boston Scientific Corp. has been somewhat stable. Over the past year, the company’s stock achieved a high of $77.99 on 06/24/24, with the lowest value for the same timeframe being $48.35, recorded on 10/13/23. 52-week price history of BSX Stock Analyzing